Download PDF
Semin Neurol 2014; 34(03): 280-292
DOI: 10.1055/s-0034-1386766
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Genetic Cerebellar Ataxias

Elsdon Storey
1   Department of Medicine (Neuroscience), Monash University, (Alfred Hospital Campus), Commercial Road, Melbourne, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
05 September 2014 (online)

    Permissions and Reprints

Abstract

This review broadly covers the commoner genetic ataxias, concentrating on their clinical features. Over the last two decades there has been a potentially bewildering profusion of newly described genetic ataxias. However, at least half of dominant ataxias (SCAs) are caused by (CAG)n repeat expansions resulting in expanded polyglutamine tracts (SCAs 1, 2, 3, 6, 7, 17, and DRPLA), although of the remainder only SCAs 8, 10, 12, 14, 15/16, and 31 are frequent enough that the described phenotype is probably representative. Though the SCAs can be difficult to separate clinically, variations in prevalence in different populations, together with various clinical and radiological features, at least help to order the pretest probabilities. The X-linked disorder, fragile-X tremor ataxia syndrome occurs in fragile-X permutation carriers, and typically causes a late-onset ataxia-plus syndrome. The recessive ataxias are not named systematically: The most frequent are Friedreich, ataxia telangiectasia, ARSACS, AOA1 and 2, and the various POLG syndromes. Although rare, several other recessive disorders such as AVED are potentially treatable and should not be missed. Another group of genetic ataxias are the dominant episodic ataxias, of which EA1 and EA2 are the most important. Lastly, the neurologist's role in ongoing management, rather than just diagnosis, is addressed.

Keywords

spinocerebellar ataxias - episodic ataxias - fragile-X tremor ataxia syndrome - recessive ataxias
 

  • References

  • 1 Gardner RJM. “SCA16” is really SCA15. J Med Genet 2008; 45 (3) 192
    PubMedGoogle Scholar
  • 2 Manto MU. Dominant ataxias. In: Manto MU, , ed. Cerebellar Disorders: A Practical Approach to Diagnosis and Management. Cambridge, UK: Cambridge University Press; 2010: 242-283
    CrossrefGoogle Scholar
  • 3 Harding AE. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'. Brain 1982; 105 (Pt 1) 1-28
    CrossrefPubMedGoogle Scholar
  • 4 Konigsmark BW, Weiner LP. The olivopontocerebellar atrophies: a review. Medicine (Baltimore) 1970; 49 (3) 227-241
    PubMedGoogle Scholar
  • 5 Orr HT. Cell biology of spinocerebellar ataxia. J Cell Biol 2012; 197 (2) 167-177
    CrossrefPubMedGoogle Scholar
  • 6 Matilla A, Roberson ED, Banfi S , et al. Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J Neurosci 1998; 18 (14) 5508-5516
    PubMedGoogle Scholar
  • 7 Kang S, Jaworski A, Ohshima K, Wells RD. Expansion and deletion of CTG repeats from human disease genes are determined by the direction of replication in E. coli. Nat Genet 1995; 10 (2) 213-218
    CrossrefPubMedGoogle Scholar
  • 8 Ikeda Y, Daughters RS, Ranum LP. Bidirectional expression of the SCA8 expansion mutation: one mutation, two genes. Cerebellum 2008; 7 (2) 150-158
    CrossrefPubMedGoogle Scholar
  • 9 Juvonen V, Kairisto V, Hietala M, Savontaus M-L. Calculating predictive values for the large repeat alleles at the SCA8 locus in patients with ataxia. J Med Genet 2002; 39 (12) 935-936
    CrossrefPubMedGoogle Scholar
  • 10 Anderson KG. How well does paternity confidence match actual paternity? Evidence from worldwide nonpaternity rates. Curr Anthropol 2006; 47: 513-520
    CrossrefPubMedGoogle Scholar
  • 11 Orr HT, Chung MY, Banfi S , et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993; 4 (3) 221-226
    CrossrefPubMedGoogle Scholar
  • 12 Rüb U, Schöls L, Paulson H , et al. Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol 2013; 104: 38-66
    CrossrefPubMedGoogle Scholar
  • 13 Donato SD, Mariotti C, Taroni F. Spinocerebellar ataxia type 1. Handb Clin Neurol 2012; 103: 399-421
    PubMedGoogle Scholar
  • 14 Imbert G, Saudou F, Yvert G , et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 1996; 14 (3) 285-291
    CrossrefPubMedGoogle Scholar
  • 15 Sanpei K, Takano H, Igarashi S , et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 1996; 14 (3) 277-284
    CrossrefPubMedGoogle Scholar
  • 16 Pulst SM, Nechiporuk A, Nechiporuk T , et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 1996; 14 (3) 269-276
    CrossrefPubMedGoogle Scholar
  • 17 Auburger GWJ. Spinocerebellar ataxia type 2. Handb Clin Neurol 2012; 103: 423-436
    PubMedGoogle Scholar
  • 18 Elden AC, Kim HJ, Hart MP , et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010; 466 (7310) 1069-1075
    CrossrefPubMedGoogle Scholar
  • 19 Kawaguchi Y, Okamoto T, Taniwaki M , et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994; 8 (3) 221-228
    CrossrefPubMedGoogle Scholar
  • 20 Riess O, Rüb U, Pastore A, Bauer P, Schöls L. SCA3: neurological features, pathogenesis and animal models. Cerebellum 2008; 7 (2) 125-137
    CrossrefPubMedGoogle Scholar
  • 21 Paulson H. Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol 2012; 103: 437-449
    PubMedGoogle Scholar
  • 22 Pedroso JL, França Jr MC, Braga-Neto P , et al. Nonmotor and extracerebellar features in Machado-Joseph disease: a review. Mov Disord 2013; 28 (9) 1200-1208
    CrossrefPubMedGoogle Scholar
  • 23 Zhuchenko O, Bailey J, Bonnen P , et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997; 15 (1) 62-69
    CrossrefPubMedGoogle Scholar
  • 24 Solodkin A, Gomez CM. Spinocerebellar ataxia type 6. Handb Clin Neurol 2012; 103: 461-473
    PubMedGoogle Scholar
  • 25 Mantuano E, Veneziano L, Jodice C, Frontali M. Spinocerebellar ataxia type 6 and episodic ataxia type 2: differences and similarities between two allelic disorders. Cytogenet Genome Res 2003; 100 (1-4) 147-153
    CrossrefPubMedGoogle Scholar
  • 26 Gomez CM, Thompson RM, Gammack JT , et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 1997; 42 (6) 933-950
    CrossrefPubMedGoogle Scholar
  • 27 David G, Abbas N, Stevanin G , et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997; 17 (1) 65-70
    CrossrefPubMedGoogle Scholar
  • 28 Martin J-J. Spinocerebellar ataxia type 7. Handb Clin Neurol 2012; 103: 475-491
    PubMedGoogle Scholar
  • 29 Koob MD, Moseley ML, Schut LJ , et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet 1999; 21 (4) 379-384
    CrossrefPubMedGoogle Scholar
  • 30 Ikeda Y, Ranum LP, Day JW. Clinical and genetic features of spinocerebellar ataxia type 8. Handb Clin Neurol 2012; 103: 493-505
    PubMedGoogle Scholar
  • 31 Gupta A, Jankovic J. Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord 2009; 15 (9) 621-626
    CrossrefPubMedGoogle Scholar
  • 32 Matsuura T, Yamagata T, Burgess DL , et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 2000; 26 (2) 191-194
    CrossrefPubMedGoogle Scholar
  • 33 Teive HA, Munhoz RP, Arruda WO, Raskin S, Werneck LC, Ashizawa T. Spinocerebellar ataxia type 10 - a review. Parkinsonism Relat Disord 2011; 17 (9) 655-661
    CrossrefPubMedGoogle Scholar
  • 34 Holmes SE, O'Hearn EE, McInnis MG , et al. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet 1999; 23 (4) 391-392
    CrossrefPubMedGoogle Scholar
  • 35 O'Hearn E, Holmes SE, Margolis RL . Spinocerebellar ataxia type 12. Handbook of Neurology 2012. ;103:535–547
  • 36 Chen D-H, Brkanac Z, Verlinde CLMJ , et al. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet 2003; 72 (4) 839-849
    CrossrefPubMedGoogle Scholar
  • 37 Chen DH, Cimino PJ, Ranum LP , et al. The clinical and genetic spectrum of spinocerebellar ataxia 14. Neurology 2005; 64 (7) 1258-1260
    CrossrefPubMedGoogle Scholar
  • 38 Chen D-H, Raskind WH, Bird TD. Spinocerebellar ataxia type 14. Handbook of Clinical Neurology 2012; 103: 555-559
    PubMedGoogle Scholar
  • 39 van de Leemput J, Chandran J, Knight MA , et al. Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet 2007; 3 (6) e108
    CrossrefPubMedGoogle Scholar
  • 40 Synofzik M, Beetz C, Bauer C , et al. Spinocerebellar ataxia type 15: diagnostic assessment, frequency, and phenotypic features. J Med Genet 2011; 48 (6) 407-412
    CrossrefPubMedGoogle Scholar
  • 41 Storey E . Spinocerebellar ataxia type 15. In: Pagon RA, Adam MP, Ardinger HH et al, eds. Gene Reviews. Seattle, WA: University of Washington; 2013. . Available at: http://www.ncbi.nlm.nih.gov/books/NBK1362/ . Accessed May 20, 2014
  • 42 Huang L, Chardon JW, Carter MT , et al. Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J Rare Dis 2012; 7: 67
    CrossrefPubMedGoogle Scholar
  • 43 Koide R, Kobayashi S, Shimohata T , et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?. Hum Mol Genet 1999; 8 (11) 2047-2053
    CrossrefPubMedGoogle Scholar
  • 44 Cloud LJ, Wilmot G. Other spinocerebellar ataxias. Handb Clin Neurol 2012; 103: 581-586
    PubMedGoogle Scholar
  • 45 Webb TE, Poulter M, Beck J , et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 2008; 131 (Pt 10) 2632-2646
    CrossrefPubMedGoogle Scholar
  • 46 Sato N, Amino T, Kobayashi K , et al. Spinocerebellar ataxia type 31 is associated with “inserted” penta-nucleotide repeats containing (TGGAA)n. Am J Hum Genet 2009; 85 (5) 544-557
    CrossrefPubMedGoogle Scholar
  • 47 Ouyang Y, Sakoe K, Shimazaki H , et al. 16q-linked autosomal dominant cerebellar ataxia: a clinical and genetic study. J Neurol Sci 2006; 247 (2) 180-186
    CrossrefPubMedGoogle Scholar
  • 48 Edener U, Bernard V, Hellenbroich Y, Gillessen-Kaesbach G, Zühlke C. Two dominantly inherited ataxias linked to chromosome 16q22.1: SCA4 and SCA31 are not allelic. J Neurol 2011; 258 (7) 1223-1227
    CrossrefPubMedGoogle Scholar
  • 49 Koide R, Ikeuchi T, Onodera O , et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 1994; 6 (1) 9-13
    CrossrefPubMedGoogle Scholar
  • 50 Nagafuchi S, Yanagisawa H, Sato K , et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 1994; 6 (1) 14-18
    CrossrefPubMedGoogle Scholar
  • 51 Tsuji S. Dentatorubral-pallidoluysian atrophy. Handb Clin Neurol 2012; 103: 587-594
    PubMedGoogle Scholar
  • 52 Kremer EJ, Pritchard M, Lynch M , et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 1991; 252 (5013) 1711-1714
    CrossrefPubMedGoogle Scholar
  • 53 Hagerman RJ, Leehey M, Heinrichs W , et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001; 57 (1) 127-130
    CrossrefPubMedGoogle Scholar
  • 54 Storey E, Billimoria P. Increased T2 signal in the middle cerebellar peduncles on MRI is not specific for fragile X premutation syndrome. J Clin Neurosci 2005; 12 (1) 42-43
    CrossrefPubMedGoogle Scholar
  • 55 Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol 2007; 6 (1) 45-55
    CrossrefPubMedGoogle Scholar
  • 56 Hagerman RJ, Leavitt BR, Farzin F , et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 2004; 74 (5) 1051-1056
    CrossrefPubMedGoogle Scholar
  • 57 Szmulewicz DJ, Waterston JA, MacDougall HG , et al. Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS): a review of the clinical features and video-oculographic diagnosis. Ann N Y Acad Sci 2011; 1233: 139-147
    CrossrefPubMedGoogle Scholar
  • 58 Campuzano V, Montermini L, Moltò MD , et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271 (5254) 1423-1427
    CrossrefPubMedGoogle Scholar
  • 59 Campuzano V, Montermini L, Lutz Y , et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997; 6 (11) 1771-1780
    CrossrefPubMedGoogle Scholar
  • 60 Delatycki MB, Paris DBBP, Gardner RJM , et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet 1999; 87 (2) 168-174
    CrossrefPubMedGoogle Scholar
  • 61 Labuda M, Labuda D, Miranda C , et al. Unique origin and specific ethnic distribution of the Friedreich ataxia GAA expansion. Neurology 2000; 54 (12) 2322-2324
    CrossrefPubMedGoogle Scholar
  • 62 Harding AE. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981; 104 (3) 589-620
    CrossrefPubMedGoogle Scholar
  • 63 Delatycki MB, Williamson R, Forrest SM. Friedreich ataxia: an overview. J Med Genet 2000; 37 (1) 1-8
    CrossrefPubMedGoogle Scholar
  • 64 Pandolfo M. Friedreich ataxia. Handb Clin Neurol 2012; 103: 275-294
    PubMedGoogle Scholar
  • 65 Hanna MG, Davis MB, Sweeney MG , et al. Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion. Mov Disord 1998; 13 (2) 339-340
    CrossrefPubMedGoogle Scholar
  • 66 Coppola G, De Michele G, Cavalcanti F , et al. Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. J Neurol 1999; 246 (5) 353-357
    CrossrefPubMedGoogle Scholar
  • 67 Subramony SH, May W, Lynch D , et al; Cooperative Ataxia Group. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology 2005; 64 (7) 1261-1262
    CrossrefPubMedGoogle Scholar
  • 68 Lynch DR, Perlman SL, Meier T. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. Arch Neurol 2010; 67 (8) 941-947
    CrossrefPubMedGoogle Scholar
  • 69 Savitsky K, Bar-Shira A, Gilad S , et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268 (5218) 1749-1753
    CrossrefPubMedGoogle Scholar
  • 70 Swift M. Genetics and epidemiology of ataxia-telangiectasia. Kroc Found Ser 1985; 19: 133-146
    PubMedGoogle Scholar
  • 71 Perlman SL, Boder Deceased E, Sedgewick RP, Gatti RA. Ataxia-telangiectasia. Handb Clin Neurol 2012; 103: 307-332
    PubMedGoogle Scholar
  • 72 Laderoute MP. Improved safety and effectiveness of imaging predicted for MR mammography. (Letter) Br J Cancer 2004; 90 (1) 278-279 , author reply 280
    CrossrefPubMedGoogle Scholar
  • 73 Bouchard JP, Barbeau A, Bouchard R, Bouchard RW. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Can J Neurol Sci 1978; 5 (1) 61-69
    PubMedGoogle Scholar
  • 74 Vermeer S, Meijer RPP, Pijl BJ , et al. ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia. Neurogenetics 2008; 9 (3) 207-214
    CrossrefPubMedGoogle Scholar
  • 75 Engert JC, Bérubé P, Mercier J , et al. ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet 2000; 24 (2) 120-125
    CrossrefPubMedGoogle Scholar
  • 76 Le Ber I, Moreira MC, Rivaud-Péchoux S , et al. Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 2003; 126 (Pt 12) 2761-2772
    CrossrefPubMedGoogle Scholar
  • 77 Date H, Onodera O, Tanaka H , et al. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet 2001; 29 (2) 184-188
    CrossrefPubMedGoogle Scholar
  • 78 Moreira MC, Barbot C, Tachi N , et al. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet 2001; 29 (2) 189-193
    CrossrefPubMedGoogle Scholar
  • 79 Quinzii CM, Kattah AG, Naini A , et al. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 2005; 64 (3) 539-541
    CrossrefPubMedGoogle Scholar
  • 80 Anheim M, Fleury M, Monga B , et al. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics 2010; 11 (1) 1-12
    Google Scholar
  • 81 Anheim M, Monga B, Fleury M , et al. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain 2009; 132 (Pt 10) 2688-2698
    CrossrefPubMedGoogle Scholar
  • 82 Moreira M-C, Klur S, Watanabe M , et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet 2004; 36 (3) 225-227
    CrossrefPubMedGoogle Scholar
  • 83 Chen Y-Z, Bennett CL, Huynh HM , et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004; 74 (6) 1128-1135
    CrossrefPubMedGoogle Scholar
  • 84 Cohen BH, Chinnery PF, Copeland WE. POLG-related disorders. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. Gene Reviews. Seattle, WA: University of Washington; 2012. . Available at: http://www.ncbi.nlm.nih.gov/books/NBK26471/ . Accessed May 20, 2014
    Google Scholar
  • 85 Ben Hamida M, Belal S, Sirugo G , et al. Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families. Neurology 1993; 43 (11) 2179-2183
    CrossrefPubMedGoogle Scholar
  • 86 Ouahchi K, Arita M, Kayden H , et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 1995; 9 (2) 141-145
    CrossrefPubMedGoogle Scholar
  • 87 Federico A, Dotti MT, Gallus GN . Cerebrotendinous xanthomatosis. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. Gene Reviews. Seattle, WA: University of Washington; 2013. . Available at: http://www.ncbi.nlm.nih.gov/books/NBK1409/ . Accessed May 21, 2014
  • 88 Cali JJ, Hsieh C-L, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 1991; 266 (12) 7779-7783
    PubMedGoogle Scholar
  • 89 Patterson M. Niemann-Pick disease Type C. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. Gene Reviews. Seattle, WA: University of Washington; 2013. . Available at: http://www.ncbi.nlm.nih.gov/books/NBK1296/ . Accessed May 21, 2014
    Google Scholar
  • 90 Browne DL, Gancher ST, Nutt JG , et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994; 8 (2) 136-140
    CrossrefPubMedGoogle Scholar
  • 91 D'Adamo MC, Hanna MG, Di Giovanni G , et al. Episodic ataxia type 1. In: Pagon RA, Adam MP, Ardinger HH et al, eds. Gene Reviews. Seattle, WA: University of Washington; 2013. . Available at: http://www.ncbi.nlm.nih.gov/books/NBK25442/ . Accessed May 19, 2014
    Google Scholar
  • 92 Baloh RW. Episodic ataxias 1 and 2. Handb Clin Neurol 2012; 103: 595-602
    PubMedGoogle Scholar
  • 93 Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW ; CINCH investigators. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 2007; 130 (Pt 10) 2484-2493
    CrossrefPubMedGoogle Scholar
  • 94 Hand PJ, Gardner RJM, Knight MA, Forrest SM, Storey E. Clinical features of a large Australian pedigree with episodic ataxia type 1. Mov Disord 2001; 16 (5) 938-939
    CrossrefPubMedGoogle Scholar
  • 95 Ophoff RA, Terwindt GM, Vergouwe MN , et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87 (3) 543-552
    CrossrefPubMedGoogle Scholar
  • 96 Jodice C, Mantuano E, Veneziano L , et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 1997; 6 (11) 1973-1978
    CrossrefPubMedGoogle Scholar
  • 97 Ilg W, Brötz D, Burkard S, Giese MA, Schöls L, Synofzik M. Long-term effects of coordinative training in degenerative cerebellar disease. Mov Disord 2010; 25 (13) 2239-2246
    CrossrefPubMedGoogle Scholar